ERBB2 and breast carcinoma: Taken together, our data support that TN or HER2+ breast cancer patients may need to be treated with surgery within a short interval after CNB, and that neoadjuvant systemic therapy may be a reasonable option for these patients if they must wait a long time for surgery [23].